Overview - The demand for cell culture bags in China is rapidly increasing due to the growth of downstream markets such as biopharmaceuticals, cell therapy, and gene therapy, with a projected demand of 9.723 million units in 2024, a year-on-year increase of 24.53% [1][8] - The market size for cell culture bags is expected to reach 1.05 billion yuan in 2024, reflecting a year-on-year growth of 21.06% [1][8] - Factors such as an aging population and increasing health awareness are driving the demand for biopharmaceutical products, further boosting the cell culture bag market [1][8] Market Policies - A series of supportive policies have been issued in China, including the "14th Five-Year Plan for the Development of the Pharmaceutical Industry" and guidelines for the production quality management of cell therapy products, creating a favorable environment for the development of the cell culture bag industry [6][7] Industry Chain - The upstream of the cell culture bag industry includes suppliers of raw materials like polyethylene and polypropylene, while the midstream involves R&D and production, and the downstream encompasses applications in biopharmaceuticals, cell therapy, and research [7][8] - Biopharmaceuticals account for over 40% of the demand for cell culture bags, primarily used in the production of monoclonal antibodies, recombinant proteins, and vaccines [8] Current Development - The cell culture bag market in China is expanding, with a projected demand of 9.723 million units and a market size of 1.05 billion yuan in 2024, driven by the rapid growth of the biopharmaceutical market [1][8] Competitive Landscape - The market is becoming increasingly competitive, with foreign companies like ThermoFisher Scientific and Corning holding significant market shares due to their advanced technology and product quality [9][10] - Domestic companies such as Guangzhou Jiet Biofilter Co., Ltd. and Wuhan Saikecheng Technology Co., Ltd. are enhancing their R&D efforts and product quality, gradually increasing their market share and competitiveness [10][11] Development Trends - The demand for single-use cell culture bags is expected to continue rising due to their advantages in reducing contamination risks and simplifying operations [12] - There is a growing focus on developing biodegradable or recyclable single-use bags to align with environmental sustainability goals [12] - Domestic companies are expected to narrow the technology gap with foreign products, leading to increased market share and potential international expansion [12]

【环球网科技报道 记者 张阳】近日，乐纯生物宣布其自主研发的Extreme™ PVDF除菌过滤膜取得重大突破，凭借高纯净度、高通量及低蛋白吸附三大核 心技术指标，实现了关键性能参数的国际领先水平，标志着中国本土生物工艺公司在保障供应链安全方面迈出了坚实的一步。 下游需求侧，供应链稳定促成国产自研机遇 面对全球供应链波动系数不断加大的挑战，乐纯生物深知源头研发能力的重要性。从2021年推出生物工艺薄膜Lekrius®膜到今年新推出的Extreme™ PVDF 滤膜，乐纯生物长期聚焦底层突破，在"双膜"（即film和membrane）材料科学源头构建技术护城河。 "夯实底层研发，才能支撑起应用产品研发的活跃度，形成门类齐全的自研产品矩阵，从而支撑起整个供应链的安全可控。"秦孙星强调。乐纯生物针对一 次性系统、细胞培养、过滤纯化三大类耗材，均采取了"攻坚底层研发、深耕应用研发、优化整体工艺"的策略，成功实现了旗下一次性配储液袋、生物反 应袋/生物反应器、细胞培养袋等产品的全国产化生产。 在过滤业务方面，随着PVDF滤膜自研并稳定量产，乐纯生物迅速推出了相应的除菌级、除病毒级过滤器产品，支持了不同领域的产品布局。公司 ...